Recombinant SOST (Blosozumab Biosimilar) antibody (Biotin)

Catalog No. ABIN7829471

The Humanized Monoclonal anti-SOST (Blosozumab Biosimilar) antibody is suitable to detect SOST (Blosozumab Biosimilar) in samples from Human.

Quick Overview for Recombinant SOST (Blosozumab Biosimilar) antibody (Biotin) (ABIN7829471)

Target: SOST (Blosozumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Monoclonal

Conjugate: This SOST (Blosozumab Biosimilar) antibody is conjugated to Biotin

Application: Please inquire

Grade: Research Grade

Product Details anti-SOST (Blosozumab Biosimilar) Antibody (Biotin)

Purpose: Biotinylated Anti-SOST(blosozumab biosimilar) mAb

Isotype: IgG4

Application Details

Comment:

Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.

Restrictions: For Research Use only

Handling

Format: Lyophilized

Reconstitution: Please see Certificate of Analysis for specific instructions of reconstitution.

Buffer: Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.

Storage: -20 °C,-80 °C

Storage Comment: Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.

Expiry Date: 12 months

Target Details for SOST (Blosozumab Biosimilar)

Target: SOST (Blosozumab Biosimilar)

Alternative Name: Blosozumab Biosimilar

Target Type: Biosimilar

Background: Synonyms Target:CDD,VBCH,DAND6,SOST1
Synonyms Antibody:LY-2541546,LY2541546,TST-002,TST002

UniProt: Q9BQB4